Modalis Therapeutics Corporation (JP:4883) has released an update.
Modalis Therapeutics Corporation announces a new executive appointment with Yosuke Nakashima stepping up as VP of Operations and Business Development, after serving as Director of Business Development and US Site Controller.
For further insights into JP:4883 stock, check out TipRanks’ Stock Analysis page.